Though insider buying has slowed during the first-quarter reporting season, some insiders continued to build stakes or bucked ...

The group, led by J. David Byerley and Samuel Lingo, has a fundraising goal of $350 million for the former scrapyard.

While Wall Street debates CVR's near-term prospects, Carl Icahn has been busy buying – not talking. In April alone, filings ...

Billionaire Carl Icahn has built an economic interest covering about 34% of Bausch Health's shares, according to a filing on ...

Billionaire Carl Icahn’s relationship with President Donald Trump has helped spark a round of recriminations within the $24 billion American ethanol industry just as it navigates one of the most ...

Increased volatility and markets in or near bear territory has not deterred some insider buyers from continuing to build ...

As Caesars approaches a decision on whether to spin off its digital business, CEO Tom Reeg welcomes Carl Icahn as part of the ...

(Reuters) -Billionaire Carl Icahn has a total economic exposure of about 34% to Bausch Health's common shares, the healthcare ...

Bausch Health has launched a shareholder rights plan—also known as a poison pill defense—designed to prevent any one entity ...

Bausch Health Companies Inc. (BHC) announced on Tuesday that billionaire activist investor Carl Icahn has a total economic ...

After enacting a “poison pill” defense to protect itself from unwanted potential buyers, Bausch Health has spotted a major ...

Shares of Bausch Health (NYSE:BHC) added ~13% in the premarket on Tuesday after the Canadian pharma major disclosed that ...